跳到主要內容

Kim Lorence H. 的 Form 4 申報

Revolution Medicines, Inc.(RVMD),2026/9/2 申報

申報編號
0001193125-26-380277
申報時間
2026/9/2 16:30 ET
交易日
2026/8/31
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $1,138 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Kim Lorence H.CIK 0001643746董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/8/31Common StockS賣出處分−300$200.56−$60,16872,790間接
2026/8/31Common StockS賣出處分−6,597$201.47F4−$1,329,116.7266,193間接
2026/8/31Common StockS賣出處分−12,919$202.48F5−$2,615,863.6753,274間接
2026/8/31Common StockS賣出處分−26,160$203.55F6−$5,324,823.5327,114間接
2026/8/31Common StockS賣出處分−7,271$204.35F7−$1,485,829.5819,843間接
2026/8/31Common StockS賣出處分−2,128$205.19F8−$436,639.8517,715間接
2026/8/31Common StockS賣出處分−625$206.15F9−$128,846.2517,090間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F4

The transaction was executed in multiple trades at prices ranging from $201.00 to $201.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F5

The transaction was executed in multiple trades at prices ranging from $202.00 to $202.9956, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F6

The transaction was executed in multiple trades at prices ranging from $203.0055 to $203.9968, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F7

The transaction was executed in multiple trades at prices ranging from $204.00 to $204.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F8

The transaction was executed in multiple trades at prices ranging from $205.00 to $205.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F9

The transaction was executed in multiple trades at prices ranging from $206.02 to $206.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)